CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Odyssey Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Odyssey Therapeutics Inc
51 Sleeper Street
Phone: (212) 841-1000p:212 841-1000 BOSTON, MA  02210  United States Fax: (302) 655-5049f:302 655-5049
Business Summary
Odyssey Therapeutics, Inc. is a biotechnology company specializing in immunomodulators and oncology medicines. The Company's primary focus is on discovering, developing, and commercializing the next generation of these medicines. It aims to transform drug discovery to accelerate the creation and efficient delivery of precision medicines that enhance patients' lives.
(Source: AI Generated Content – Human Reviewed & Approved)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Jeffrey M.Leiden 69
President, Chief Executive Officer, Co-Founder, Director Gary D.Glick
Co-Founder, Chief Innovation Officer David L.Pompliano
Executive Vice President - Cancer Biology RobertAbraham
Executive Vice President - Enabling Sciences JeffreyHermes

Subsidiaries
Business Name Address City State/Province Country
ODYSSEY THERAPEUTICS GMBH INDUSTRIEPARK HAuCHST GEBAaUDE G FRANKFURT

Business Names
Business Name
Daros Inc.
Demuris Limited
Immunology Discovery, LLC
6 additional Business Names available in full report.

General Information
Number of Employees: 151 (As of 12/31/2024)
Federal Tax Id: 863384382
Fax Number: (302) 655-5049


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, August 7, 2025